Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CECR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSLP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLAMF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRBC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AGPAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RYR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506125 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927943 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHADL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQSEC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABL2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4K2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on